Back
Intellia Therapeutics Vs. NeuroMetrix Industry Stock Comparison
Sell
45
NTLA
Intellia Therapeutics
Last Price:
25.88
Seasonality Move:
33.25%
Sell
29
NURO
NeuroMetrix
Last Price:
3.98
Seasonality Move:
3.25%
Sell
45
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy, Sell or Hold?
- The current Intellia Therapeutics [NTLA] share price is $26.22. The Score for NTLA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- NTLA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
NeuroMetrix (NURO)
is a Sell
Is NeuroMetrix a Buy, Sell or Hold?
- The current NeuroMetrix [NURO] share price is $4.04. The Score for NURO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
- NURO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NTLA Stock Price Chart
What is Intellia Therapeutics's stock price today?
-
The Intellia Therapeutics share price today is $26.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NTLA is experiencing slight buying pressure.
NURO Stock Price Chart
What is NeuroMetrix's stock price today?
-
The NeuroMetrix share price today is $4.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NURO is experiencing slight buying pressure.
NTLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.51 | Buy |
Relative Strength Index (14 RSI): | 62.46 | Buy |
Chaikin Money Flow: | 117641 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.24 - 24.92) | Buy |
Bollinger Bands (100): | (23.55 - 29.45) | Sell |
NURO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 43.5 | Sell |
Chaikin Money Flow: | 746 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.93 - 4.59) | Sell |
Bollinger Bands (100): | (3.23 - 4.21) | Buy |
NTLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.26 | Buy |
20-day SMA: | 23.39 | Buy |
50-day SMA: | 24.93 | Buy |
200-day SMA: | 29.22 | Sell |
8-day EMA: | 25.36 | Buy |
20-day EMA: | 24.39 | Buy |
50-day EMA: | 24.9 | Buy |
200-day EMA: | 29.74 | Sell |
NURO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.32 | Sell |
20-day SMA: | 4.39 | Sell |
50-day SMA: | 4.09 | Sell |
200-day SMA: | 4.33 | Sell |
8-day EMA: | 4.26 | Sell |
20-day EMA: | 4.27 | Sell |
50-day EMA: | 4.1 | Sell |
200-day EMA: | 5.28 | Sell |
Intellia Therapeutics Earnings Growth & NTLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.26 per share, and a decrease next year of $0.19 per share.
NeuroMetrix Earnings Growth & NURO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intellia Therapeutics Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NeuroMetrix Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |